|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Galmed Pharmaceuticals (NASDAQ: GLMD) through any online brokerage.
There are no as such competitors for Galmed Pharmaceuticals.
The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Canaccord Genuity on May 17, 2021. The analyst firm set a price target for 21.00 expecting GLMD to rise to within 12 months (a possible 609.46% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Galmed Pharmaceuticals (NASDAQ: GLMD) is $2.96 last updated Fri Jun 18 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Galmed Pharmaceuticals.
There is no upcoming split for Galmed Pharmaceuticals.
Galmed Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.